The first discovered fusion gene is BCR-ABL13–5, which is formed by a translocation event involving chromosome 9 and 22 and identified as the predominant factor predisposing to chronic myelogenous leukaemia (CML). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.